or Try an Advanced Search...

    Technical Analysis for ICCM - IceCure Medical Ltd.

    Grade Last Price % Change Price Change
    D 1.18 0.60% 0.01
    ICCM closed down 3.31 percent on Wednesday, May 8, 2024, on 65 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical ICCM trend table...
    Date Alert Name Type % Chg
    Inside Day Range Contraction 0.60%
    Gapped Down Weakness 0.60%
    20 DMA Resistance Bearish -2.73%
    50 DMA Resistance Bearish -2.73%
    Pocket Pivot Bullish Swing Setup -2.73%
    Doji - Bearish? Reversal -2.73%
    Doji - Bullish? Reversal -2.73%
    Outside Day Range Expansion -2.73%
    Gapped Up Strength -2.73%
    NR7 Range Contraction -1.09%
    Older End-of-Day Signals for ICCM ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance about 2 hours ago
    Up 1% about 2 hours ago
    Fell Below Previous Day's Low about 3 hours ago
    Possible Inside Day about 24 hours ago
    2x Volume Pace 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ICCM Chart by TradingView
    Basic chart:

    Profile

    Founded in 2006, Israel-based IceCure Medical develops and markets an advanced liquid-nitrogen-based cryoablation therapy for the treatment of tumors (benign and cancerous) by freezing, with the primary focus areas being breast, kidney, bone and lung cancer. Its minimally-invasive technology is a safe and effective alternative to hospital surgical tumor removal that is easily performed in a relatively short procedure. The system is marketed and sold worldwide, after receiving FDA and CE approvals.
    Classification
    Sector: Healthcare
    Industry: Medical Care Facilities
    Keywords: Medicine Clinical Medicine Tumor Breast Cancer FDA Interventional Radiology Lung Cancer Cryoablation Interventional Oncology

    Is ICCM a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 7 Independent Study Results in Japan Demonstrate Zero (0%) Breast Cancer Local Recurrence 5 Years Following Treatment with IceCure's ProSense®, Adding to Continued Positive Data Published Globally
    Apr 18 IceCure Medical (ICCM) Submits Final Cryoablation Data to FDA
    Apr 15 IceCure Medical Reports Final ICE3 Breast Cancer Cryoablation Trial Results of 100% Patient and Physician Satisfaction and 96.3% Recurrence Free Rate: Data Submitted to FDA Requesting Marketing Authorization to Treat Early-Stage Breast Cancer
    Apr 4 IceCure Medical Ltd (NASDAQ:ICCM) Q4 2023 Earnings Call Transcript
    Apr 3 IceCure Medical Ltd. (ICCM) Q4 2023 Earnings Call Transcript
    Apr 3 IceCure Medical reports FY results
    Apr 3 IceCure Medical Reports Full Year 2023 Financial Results: Global ProSense® and Disposables Sales Increase 26% as Company Continues Transition to Commercial Phase and Expects to Submit ICE3 Breast Cancer Study Data to FDA this Month for Marketing Clearance
    Apr 2 IceCure Submits FDA Regulatory Filing for New XSense™ Cryoablation System with Cryoprobes
    Mar 27 IceCure Medical to Report 2023 Full Year Financial & Operational Results on April 3, 2024
    Mar 19 IceCure Medical Reports Positive Topline Results From ICE3 Cryoablation Breast Cancer Study: Achievement of 96.39% Recurrence Free Rate Brings Company One Step Closer to Providing Women a Non-Surgical Alternative to Lumpectomy
    See more ICCM news...

    Comments

    S

    SociableGnat503 7 months ago

    Is anyone here following this one? 

    0 Reply
    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.57
    52 Week Low 0.52
    Average Volume 444,351
    200-Day Moving Average 1.09
    50-Day Moving Average 1.23
    20-Day Moving Average 1.22
    10-Day Moving Average 1.19
    Average True Range 0.06
    RSI (14) 40.12
    ADX 21.33
    +DI 18.78
    -DI 20.39
    Chandelier Exit (Long, 3 ATRs) 1.27
    Chandelier Exit (Short, 3 ATRs) 1.21
    Upper Bollinger Bands 1.31
    Lower Bollinger Band 1.13
    Percent B (%b) 0.22
    BandWidth 14.87
    MACD Line -0.02
    MACD Signal Line -0.02
    MACD Histogram -0.0025
    Fundamentals Value
    Market Cap 53.5 Million
    Num Shares 45.7 Million
    EPS -0.36
    Price-to-Earnings (P/E) Ratio -3.25
    Price-to-Sales 22.29
    Price-to-Book 4.42
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.25
    Resistance 3 (R3) 1.25 1.24 1.23
    Resistance 2 (R2) 1.24 1.22 1.23 1.23
    Resistance 1 (R1) 1.20 1.21 1.20 1.20 1.22
    Pivot Point 1.19 1.19 1.18 1.18 1.19
    Support 1 (S1) 1.15 1.17 1.15 1.15 1.12
    Support 2 (S2) 1.14 1.16 1.13 1.11
    Support 3 (S3) 1.10 1.14 1.11
    Support 4 (S4) 1.10